Cargando…

Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery

PURPOSE: Cardiopulmonary bypass is known to alter propofol pharmacokinetics in patients undergoing cardiac surgery. However, few studies have evaluated the impact of these alterations on postoperative pharmacodynamics. This study was designed to test the hypothesis that changes in propofol pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Ricardo Antonio G., Jorge Santos, Silvia Regina C., White, Paul F., Pereira, Valéria A., Silva Filho, Carlos R., Malbouisson, Luiz M. S., Carmona, Maria José C.
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666455/
https://www.ncbi.nlm.nih.gov/pubmed/19330248
http://dx.doi.org/10.1590/S1807-59322009000300012
_version_ 1782166046564679680
author Barbosa, Ricardo Antonio G.
Jorge Santos, Silvia Regina C.
White, Paul F.
Pereira, Valéria A.
Silva Filho, Carlos R.
Malbouisson, Luiz M. S.
Carmona, Maria José C.
author_facet Barbosa, Ricardo Antonio G.
Jorge Santos, Silvia Regina C.
White, Paul F.
Pereira, Valéria A.
Silva Filho, Carlos R.
Malbouisson, Luiz M. S.
Carmona, Maria José C.
author_sort Barbosa, Ricardo Antonio G.
collection PubMed
description PURPOSE: Cardiopulmonary bypass is known to alter propofol pharmacokinetics in patients undergoing cardiac surgery. However, few studies have evaluated the impact of these alterations on postoperative pharmacodynamics. This study was designed to test the hypothesis that changes in propofol pharmacokinetics increase hypnotic effects after cardiopulmonary bypass. METHODS: Twenty patients scheduled for on-pump coronary artery bypass graft (group, n=10) or off-pump coronary artery bypass graft (group, n=10) coronary artery bypass grafts were anesthetized with sufentanil and a propofol target controlled infusion (2.0 μg/mL). Depth of hypnosis was monitored using the bispectral index. Blood samples were collected from the induction of anesthesia up to 12 hours after the end of propofol infusion, at predetermined intervals. Plasma propofol concentrations were measured using high-performance liquid chromatography, followed by a non-compartmental propofol pharmacokinetic analysis. Data were analyzed using ANOVA, considering p<0.05 as significant. RESULTS: After cardiopulmonary bypass, despite similar plasma propofol concentrations in both groups, bispectral index values were lower in the on-pump coronary artery bypass graft group. Time to extubation after the end of propofol infusion was greater in the on-pump coronary artery bypass graft group (334 ± 117 vs. 216 ± 85 min, p = 0.04). Patients undergoing cardiopulmonary bypass had shorter biological (1.82 ± 0.5 vs. 3.67 ± 1.15h, p < 0.01) and terminal elimination (6.27 ± 1.29 vs. 10.5h ± 2.18, p < 0.01) half-life values, as well as higher total plasma clearance (28.36 ± 11.40 vs.18.29 ± 7.67 mL/kg/min, p = 0.03), compared to patients in the off-pump coronary artery bypass graft group. CONCLUSION: Aside from the increased sensitivity of the brain to anesthetics after cardiopulmonary bypass, changes in propofol pharmacokinetics may contribute to its central nervous system effects.
format Text
id pubmed-2666455
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-26664552009-05-13 Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery Barbosa, Ricardo Antonio G. Jorge Santos, Silvia Regina C. White, Paul F. Pereira, Valéria A. Silva Filho, Carlos R. Malbouisson, Luiz M. S. Carmona, Maria José C. Clinics Clinical Sciences PURPOSE: Cardiopulmonary bypass is known to alter propofol pharmacokinetics in patients undergoing cardiac surgery. However, few studies have evaluated the impact of these alterations on postoperative pharmacodynamics. This study was designed to test the hypothesis that changes in propofol pharmacokinetics increase hypnotic effects after cardiopulmonary bypass. METHODS: Twenty patients scheduled for on-pump coronary artery bypass graft (group, n=10) or off-pump coronary artery bypass graft (group, n=10) coronary artery bypass grafts were anesthetized with sufentanil and a propofol target controlled infusion (2.0 μg/mL). Depth of hypnosis was monitored using the bispectral index. Blood samples were collected from the induction of anesthesia up to 12 hours after the end of propofol infusion, at predetermined intervals. Plasma propofol concentrations were measured using high-performance liquid chromatography, followed by a non-compartmental propofol pharmacokinetic analysis. Data were analyzed using ANOVA, considering p<0.05 as significant. RESULTS: After cardiopulmonary bypass, despite similar plasma propofol concentrations in both groups, bispectral index values were lower in the on-pump coronary artery bypass graft group. Time to extubation after the end of propofol infusion was greater in the on-pump coronary artery bypass graft group (334 ± 117 vs. 216 ± 85 min, p = 0.04). Patients undergoing cardiopulmonary bypass had shorter biological (1.82 ± 0.5 vs. 3.67 ± 1.15h, p < 0.01) and terminal elimination (6.27 ± 1.29 vs. 10.5h ± 2.18, p < 0.01) half-life values, as well as higher total plasma clearance (28.36 ± 11.40 vs.18.29 ± 7.67 mL/kg/min, p = 0.03), compared to patients in the off-pump coronary artery bypass graft group. CONCLUSION: Aside from the increased sensitivity of the brain to anesthetics after cardiopulmonary bypass, changes in propofol pharmacokinetics may contribute to its central nervous system effects. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009-03 /pmc/articles/PMC2666455/ /pubmed/19330248 http://dx.doi.org/10.1590/S1807-59322009000300012 Text en Copyright © 2009 Hospital das Clínicas da FMUSP
spellingShingle Clinical Sciences
Barbosa, Ricardo Antonio G.
Jorge Santos, Silvia Regina C.
White, Paul F.
Pereira, Valéria A.
Silva Filho, Carlos R.
Malbouisson, Luiz M. S.
Carmona, Maria José C.
Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title_full Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title_fullStr Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title_full_unstemmed Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title_short Effects of Cardiopulmonary Bypass on Propofol Pharmacokinetics and Bispectral Index During Coronary Surgery
title_sort effects of cardiopulmonary bypass on propofol pharmacokinetics and bispectral index during coronary surgery
topic Clinical Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666455/
https://www.ncbi.nlm.nih.gov/pubmed/19330248
http://dx.doi.org/10.1590/S1807-59322009000300012
work_keys_str_mv AT barbosaricardoantoniog effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT jorgesantossilviareginac effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT whitepaulf effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT pereiravaleriaa effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT silvafilhocarlosr effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT malbouissonluizms effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery
AT carmonamariajosec effectsofcardiopulmonarybypassonpropofolpharmacokineticsandbispectralindexduringcoronarysurgery